United States · Amendment · SAMDT
SAMDT 1140 (105th)
To require that entities and individuals accredited to conduct reviews of device notifications be subject to the conflict of interest standards that apply to employees of the Food and Drug Administration.
Introduced
—
Last action
—
Status
Amendment SP 1140 not agreed to in Senate by Yea-Nay Vote. 40-59. Record Vote No: 252.
Sponsors
Sen. Durbin, Richard J. [D-IL]
Subjects
Discovery layer
Source updated
25 February 2022
Records
Official amendment SAMDT 1140 (105th) from United States at United States Congress. Status: Amendment SP 1140 not agreed to in Senate by Yea-Nay Vote. 40-59. Record Vote No: 252..
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Sponsors
- Sen. Durbin, Richard J. [D-IL] · D · Sponsor
Related records
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/amendment/105th-congress/samdt-1140
- Open data entity: https://api.congress.gov/v3/amendment/105/samdt/1140
- us · 105-samdt-1140 · source updated 25 February 2022